Truist Financial
DNTH icon

Truist Financial’s Dianthus Therapeutics DNTH Stock Holding History

Truist Financial’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$423K Buy
4,806
+1,027
+27% +$107K ﹤0.01% 2307
2026
Q2 		$368K Buy
3,779
+364
+11% +$31.8K ﹤0.01% 2415
2026
Q1 		$287K Buy
+3,415
New +$198K ﹤0.01% 2418
2022
Q1 		– Sell
-7,989
Closed -$566K – 2713
2021
Q4 		$566K Buy
7,989
+125
+2% +$12.6K ﹤0.01% 1937
2021
Q3 		$916K Buy
7,864
+456
+6% +$53.1K ﹤0.01% 1664
2021
Q2 		$1.16M Buy
7,408
+482
+7% +$88.5K ﹤0.01% 1552
2021
Q1 		$1.31M Sell
6,926
-1,344
-16% -$226K ﹤0.01% 1432
2020
Q4 		$1.04M Buy
8,270
+187
+2% +$21.2K ﹤0.01% 1456
2020
Q3 		$879K Buy
8,083
+2,718
+51% +$322K ﹤0.01% 1430
2020
Q2 		$645K Buy
5,365
+1,475
+38% +$208K ﹤0.01% 1492
2020
Q1 		$391K Buy
3,890
+2,946
+312% +$546K ﹤0.01% 1697
2019
Q4 		$229K Buy
+944
New +$176K ﹤0.01% 2293

Other funds holding DNTH

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Moody Aldrich Partners
Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Peak Financial Advisors
Peak Financial Advisors Denver, Colorado $232M AUM 12.16% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
QP Wealth Management
QP Wealth Management Eatontown, New Jersey $66.5M AUM 63.94% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Truist Financial's DNTH Position: Q3 2026 in Review

Truist Financial increased its Dianthus Therapeutics (DNTH) stake by 27% in Q3 2026, buying an estimated $107K and bringing the position to 4,806 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #2307.

Truist Financial first reported a position in DNTH in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.31M in Q1 2021. 39 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • Truist Financial held 4,806 shares of Dianthus Therapeutics worth $423K as of Q3 2026.
  • Truist Financial bought 1,027 Dianthus Therapeutics shares in Q3 2026, an estimated $107K.
  • Dianthus Therapeutics made up ﹤0.01% of Truist Financial's portfolio in Q3 2026, its #2307 holding.
  • Truist Financial first reported a position in Dianthus Therapeutics in Q4 2019 and has held it in 12 quarters since.
  • Truist Financial's Dianthus Therapeutics position peaked at $1.31M in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on Truist Financial's 13F filing for Q3 2026, filed 30 Oct 2026.